John Hohneker - May 16, 2024 Form 4 Insider Report for ArriVent BioPharma, Inc. (AVBP)

Role
Director
Signature
/s/ James Kastenmayer, Attorney-in-Fact for John Hohneker
Stock symbol
AVBP
Transactions as of
May 16, 2024
Transactions value $
$0
Form type
4
Date filed
5/20/2024, 05:30 PM
Previous filing
Apr 1, 2024
Next filing
May 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVBP Stock Option (right to buy) Award $0 +29.6K $0.00 29.6K May 16, 2024 Common Stock 29.6K $20.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest annually in equal installments over three years, subject to the Reporting Person's continued service through the applicable vesting date.